Literature DB >> 21398641

Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Brian J Borkowski1, Yaser Cheema, Atta U Shahbaz, Syamal K Bhattacharya, Karl T Weber.   

Abstract

An ongoing loss of cardiomyocytes to apoptotic and necrotic cell death pathways contributes to the progressive nature of heart failure. The pathophysiological origins of necrotic cell loss relate to the neurohormonal activation that accompanies acute and chronic stressor states and which includes effector hormones of the adrenergic nervous system. Fifty years ago, Albrecht Fleckenstein and coworkers hypothesized the hyperadrenergic state, which accompanies such stressors, causes cardiomyocyte necrosis based on catecholamine-initiated excessive intracellular Ca(2+) accumulation (EICA), and mitochondrial Ca(2+) overloading in particular, in which the ensuing dysfunction and structural degeneration of these organelles leads to necrosis. In recent years, two downstream factors have been identified which, together with EICA, constitute a signal-transducer-effector pathway: (i) mitochondria-based induction of oxidative stress, in which the rate of reactive oxygen metabolite generation exceeds their rate of detoxification by endogenous antioxidant defences; and (ii) the opening of the mitochondrial inner membrane permeability transition pore (mPTP) followed by organellar swelling and degeneration. The pathogenesis of stress-related cardiomyopathy syndromes is likely related to this pathway. Other factors which can account for cytotoxicity in stressor states include: hypokalaemia; ionized hypocalcaemia and hypomagnesaemia with resultant elevations in parathyroid hormone serving as a potent mediator of EICA; and hypozincaemia with hyposelenaemia, which compromise antioxidant defences. Herein, we revisit the Fleckenstein hypothesis of EICA in leading to cardiomyocyte necrosis and the central role played by mitochondria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398641      PMCID: PMC3147115          DOI: 10.1093/eurheartj/ehr063

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  158 in total

Review 1.  Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit.

Authors:  Mitchell S Buckley; Jaclyn M Leblanc; Michael J Cawley
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

2.  Diuretic use, progressive heart failure, and death in patients in the DIG study.

Authors:  Michael Domanski; Xin Tian; Mark Haigney; Bertram Pitt
Journal:  J Card Fail       Date:  2006-06       Impact factor: 5.712

3.  Key role of Ca in the production of noncoronarogenic myocardial necroses.

Authors:  A Fleckenstein; J Kanke; H J Döring; O Leder
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1975

4.  Epinephrine-induced hypokalemia: the role of beta adrenoceptors.

Authors:  J L Reid; K F Whyte; A D Struthers
Journal:  Am J Cardiol       Date:  1986-04-25       Impact factor: 2.778

Review 5.  Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia.

Authors:  Jay H Kramer; Christopher Spurney; Micaela Iantorno; Constantine Tziros; I-Tong Mak; M Isabel Tejero-Taldo; Joanna J Chmielinska; Andrei M Komarov; William B Weglicki
Journal:  Am J Med Sci       Date:  2009-07       Impact factor: 2.378

6.  Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality.

Authors:  R P Karlsberg; P E Cryer; R Roberts
Journal:  Am Heart J       Date:  1981-07       Impact factor: 4.749

7.  Clinical significance of cardiac troponins I and T in acute heart failure.

Authors:  Tuomo Ilva; Johan Lassus; Krista Siirilä-Waris; John Melin; Keijo Peuhkurinen; Kari Pulkki; Markku S Nieminen; Harri Mustonen; Pekka Porela; Veli-Pekka Harjola
Journal:  Eur J Heart Fail       Date:  2008-07-02       Impact factor: 15.534

8.  Zinc concentrations in serum as related to myocardial infarction.

Authors:  J Lekakis; A Kalofoutis
Journal:  Clin Chem       Date:  1980-11       Impact factor: 8.327

9.  The serum selenium concentration of patients with acute myocardial infarction.

Authors:  O Oster; M Drexler; J Schenk; T Meinertz; W Kasper; C J Schuster; W Prellwitz
Journal:  Ann Clin Res       Date:  1986

10.  Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agents: toward a new bioassay for beta-blockers.

Authors:  Lip-Bun Tan; Jatin G Burniston; William A Clark; YeeLan Ng; David F Goldspink
Journal:  J Cardiovasc Pharmacol       Date:  2003-04       Impact factor: 3.105

View more
  22 in total

Review 1.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

Review 2.  Oxidative stress in heart failure: what are we missing?

Authors:  Douglas B Sawyer
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

3.  Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.

Authors:  Mazen Shaheen; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Exp Clin Cardiol       Date:  2011

Review 4.  Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.

Authors:  Lucas Liaudet; Belinda Calderari; Pal Pacher
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

5.  Phosphoproteome mapping of cardiomyocyte mitochondria in a rat model of heart failure.

Authors:  Francesco Giorgianni; M Usman Khan; Karl T Weber; Ivan C Gerling; Sarka Beranova-Giorgianni
Journal:  Mol Cell Biochem       Date:  2014-01-07       Impact factor: 3.396

6.  Clinical and echocardiographic correlates of serum copper and zinc in acute and chronic heart failure.

Authors:  Ioannis Alexanian; John Parissis; Dimitrios Farmakis; Sotirios Athanaselis; Loukas Pappas; Gerasimos Gavrielatos; Constantinos Mihas; Ioannis Paraskevaidis; Antonios Sideris; Dimitrios Kremastinos; Chaido Spiliopoulou; Maria Anastasiou-Nana; John Lekakis; Gerasimos Filippatos
Journal:  Clin Res Cardiol       Date:  2014-06-08       Impact factor: 5.460

Review 7.  Zinc and the prooxidant heart failure phenotype.

Authors:  Nephertiti Efeovbokhan; Syamal K Bhattacharya; Robert A Ahokas; Yao Sun; Ramareddy V Guntaka; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2014-10       Impact factor: 3.105

8.  The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.

Authors:  Georges Saab; Andrew S Bomback; Samy I McFarlane; Suying Li; Shu-Cheng Chen; Peter A McCullough; Adam Whaley-Connell
Journal:  J Clin Endocrinol Metab       Date:  2012-10-12       Impact factor: 5.958

Review 9.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

10.  Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice.

Authors:  Jeffrey J Hsu; Jinxiu Lu; Soban Umar; Jason T Lee; Rajan P Kulkarni; Yichen Ding; Chih-Chiang Chang; Tzung K Hsiai; Akishige Hokugo; Ioannis Gkouveris; Sotirios Tetradis; Ichiro Nishimura; Linda L Demer; Yin Tintut
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.